Glaxo Wellcome Trizivir
Executive Summary
NDA submitted for triple combination tablet for treatment of HIV infection. Each tablet contains Epivir (150 mg lamivudine), Retrovir (300 mg zidovudine) and Ziagen (300 mg abacavir) and will be taken twice daily. An application was also submitted in Europe